menu
    • menu
    [{"orgOrder":0,"company":"SINTETICA SA","sponsor":"Harrow Health","pharmaFlowCategory":"D","therapeuticArea":"Ophthalmology","country":"SWITZERLAND","productType":"Small molecule","year":"2021","type":"Acquisition","leadProduct":"AMP-100","moa":"","graph1":"Ophthalmology","graph2":"Phase III","graph3":"SINTETICA SA","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Ophthalmology","amount2New":0,"dosageForm":"Intravitreal Injection","sponsorNew":"SINTETICA SA \/ Harrow Health","highestDevelopmentStatusID":"10","companyTruncated":"SINTETICA SA \/ Harrow Health"},{"orgOrder":0,"company":"SINTETICA SA","sponsor":"Not Applicable","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"SWITZERLAND","productType":"Small molecule","year":"2023","type":"Not Applicable","leadProduct":"Lidocaine Hydrochloride","moa":"","graph1":"Neurology","graph2":"Approved","graph3":"SINTETICA SA","amount2":0,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"","sponsorNew":"SINTETICA SA \/ Not Applicable","highestDevelopmentStatusID":"12","companyTruncated":"SINTETICA SA \/ Not Applicable"}]

    Find Clinical Drug Pipeline Developments & Deals by SINTETICA SA

    Menu

    SINTETICA SA

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
    filter

    Year

    filter

    DEALS // DEV.

    filter

    Country

    filter
    Sponsor
    filter

    Therapeutic Area

    filter

    Study Phase

    filter

    Deal Type

    filter

    Product Type

    filter

    Dosage Form

    filter

    Lead Product

    filter

    Target

    refresh Filters
    refresh Reset Filter
    refresh Reset Filter
    price-trend All Developments

    Therapeutic Area by Lead Product

    ForexGraph

    Study Phase by Lead Product

    ForexGraph

    Company by Lead Product

    ForexGraph

    Top Deals by Deal Size (USD bn)

    ForexGraph

    01

    SINTETICA SA

    Switzerland arrow
    BePharma
    Not Confirmed

    SINTETICA SA

    Switzerland arrow
    BePharma
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Lidocaine Hydrochloride

    Therapeutic Area : Neurology

    Study Phase : Approved

    Sponsor : Not Applicable

    Deal Size : Not Applicable

    Deal Type : Not Applicable

    DEALS_DEV arrow-down

    Sintetica US Launches Lidocaine Hydrochloride Injection, USP 1%, 2% and 4%

    Details : Lidocaine hydrochloride is a local anesthetic used in a wide variety of superficial and invasive procedures, it works by blocking sodium channels and thus decreasing the rate of contractions of the heart.

    Product Name : Lidocaine Hydrochloride-Generic

    Product Type : Small molecule

    Upfront Cash : Not Applicable

    March 27, 2023

    Lead Product(s) : Lidocaine Hydrochloride

    Therapeutic Area : Neurology

    Highest Development Status : Approved

    Sponsor : Not Applicable

    Deal Size : Not Applicable

    Deal Type : Not Applicable

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    02

    SINTETICA SA

    Switzerland arrow
    BePharma
    Not Confirmed

    SINTETICA SA

    Switzerland arrow
    BePharma
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : AMP-100

    Therapeutic Area : Ophthalmology

    Study Phase : Phase III

    Sponsor : Harrow Health

    Deal Size : Undisclosed

    Deal Type : Acquisition

    DEALS_DEV arrow-down

    Harrow Health Acquires Patented Ophthalmic Surgical Drug Candidate from Sintetica

    Details : AMP-100 is a patented, innovative ocular surface anesthetic drug candidate, with safety and efficacy supported by a recently completed Phase 3 study that successfully compared the efficacy and tolerability of AMP-100 to current standards of care.

    Product Name : AMP-100

    Product Type : Small molecule

    Upfront Cash : Undisclosed

    July 27, 2021

    Lead Product(s) : AMP-100

    Therapeutic Area : Ophthalmology

    Highest Development Status : Phase III

    Sponsor : Harrow Health

    Deal Size : Undisclosed

    Deal Type : Acquisition

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth